Kansas City animal health company Synbiotics Corp. said Wednesday that it will sell to Pfizer Animal Health. The deal is expected to close later this week.
In a release, the companies said Synbiotics shareholders would receive 30.6 cents a share in cash as part of the transaction, of which just less than 2 cents a share would be held in escrow for any claims about Synbiotics’ representations to Pfizer.